BioSpace News Archive

Medidata, a Dassault Systèmes company and the global leader in creating end-to-end solutions to support the entire clinical development process, announced its expanded partnership with Horizon Therapeutics plc.

InnoCare Pharma, a leading biopharmaceutical company, announced two subscription agreements with Gaoling and YHG, a company of Hillhouse Capital Group, and Vivo Opportunity Fund, L.P, a company of Vivo Capital VIII, LLC.

Commercial launch activities for Idefirix® progressing as planned; Patient recruitment in clinical studies reinitiated in December 2020; Company financed into 2023

Core One Labs Inc. is pleased to announce it has entered into a letter of intent dated January 20, 2021 with Ketamine Infusion Centers of Texas, LLC, an arms-length-party, to review a potential acquisition of KICT.

Study will measure the impact of comprehensive genomic profiling on access to, and uptake of, personalized medicines and on clinical outcomes for patients

Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, announced that it has made two achievements for its Covid-19 new drug candidate Antroquinonol® : receiving positive response after DMC review in Phase 2 clinical trial and signed first agreement in global licensing progress.

LabTwin GmbH, a company developing the world’s first voice and AI-powered digital lab assistant, announced an official collaboration with Covestro AG.

First fiscal quarter revenues of $5.315 billion grew 25.8% on a reported basis. On a currency-neutral basis, revenues increased 24.3%.

Because Alzheimer’s disease is such a serious concern for seniors, any advocacy group’s recommendations for a drug company’s proposed therapy must be science-based and above reproach, says Leslie Norins, MD, PhD, FIDSA, CEO of Alzheimer’s Germ Quest.

Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 18, 2021 at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year 2020, recent business developments, financial outlook for full year 2021, and revenue guidance for the first quarter of 2021.